These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


453 related items for PubMed ID: 12735659

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Budesonide/formoterol in a single inhaler rapidly relieves methacholine-induced moderate-to-severe bronchoconstriction.
    van der Woude HJ, Boorsma M, Bergqvist PB, Winter TH, Aalbers R.
    Pulm Pharmacol Ther; 2004; 17(2):89-95. PubMed ID: 15123230
    [Abstract] [Full Text] [Related]

  • 7. Onset of bronchodilation of budesonide/formoterol vs. salmeterol/fluticasone in single inhalers.
    Palmqvist M, Arvidsson P, Beckman O, Peterson S, Lötvall J.
    Pulm Pharmacol Ther; 2001; 14(1):29-34. PubMed ID: 11162416
    [Abstract] [Full Text] [Related]

  • 8. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
    Frois C, Wu EQ, Ray S, Colice GL.
    Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019
    [Abstract] [Full Text] [Related]

  • 9. Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction.
    Lindberg A, Szalai Z, Pullerits T, Radeczky E.
    Respirology; 2007 Sep; 12(5):732-9. PubMed ID: 17875063
    [Abstract] [Full Text] [Related]

  • 10. Treatment comparison of budesonide/formoterol with salmeterol/fluticasone propionate in adults aged > or =16 years with asthma: post hoc analysis of a randomized, double-blind study.
    Kuna P.
    Clin Drug Investig; 2010 Sep; 30(9):565-79. PubMed ID: 20593912
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Combination of budesonide/formoterol more effective than fluticasone/salmeterol in preventing exacerbations in chronic obstructive pulmonary disease: the PATHOS study.
    Larsson K, Janson C, Lisspers K, Jørgensen L, Stratelis G, Telg G, Ställberg B, Johansson G.
    J Intern Med; 2013 Jun; 273(6):584-94. PubMed ID: 23495860
    [Abstract] [Full Text] [Related]

  • 16. Effects of formoterol, salmeterol or oxitropium bromide on airway responses to salbutamol in COPD.
    Cazzola M, Di Perna F, Noschese P, Vinciguerra A, Calderaro F, Girbino G, Matera MG.
    Eur Respir J; 1998 Jun; 11(6):1337-41. PubMed ID: 9657576
    [Abstract] [Full Text] [Related]

  • 17. Faster onset of action of formoterol versus salmeterol in patients with chronic obstructive pulmonary disease: a multicenter, randomized study.
    Cote C, Pearle JL, Sharafkhaneh A, Spangenthal S.
    Pulm Pharmacol Ther; 2009 Feb; 22(1):44-9. PubMed ID: 19071226
    [Abstract] [Full Text] [Related]

  • 18. Comparison of a combination of tiotropium plus formoterol to salmeterol plus fluticasone in moderate COPD.
    Rabe KF, Timmer W, Sagkriotis A, Viel K.
    Chest; 2008 Aug; 134(2):255-262. PubMed ID: 18403672
    [Abstract] [Full Text] [Related]

  • 19. Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone.
    Bousquet J, Boulet LP, Peters MJ, Magnussen H, Quiralte J, Martinez-Aguilar NE, Carlsheimer A.
    Respir Med; 2007 Dec; 101(12):2437-46. PubMed ID: 17905575
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.